Guy Fagherazzi, PhD

10 selected Research Luxembourg results - May 2025 Development of a tool to evaluate AI performance in Luxembourgish; Public participation in support of urban biodiversity; News on Luxembourg's population growth; Immune system dysfunction contributing...

📢 10 fascinating #ResearchLuxembourg results

💡 Discover #Luxembourg #science & #research news from May 2025 you might have missed.

🔗 www.researchluxembourg.org/en/10-select...

@uni.lu @statec-luxembourg.bsky.social @fnr.lu @guyfagherazzi.bsky.social @jcabot.bsky.social

Can #AI detect #type2diabetes from your #voice?🎙️

Scientists at @lih-luxembourg.bsky.social are developing a non-invasive screening tool that analyses vocal patterns to identify diabetes-related changes.

Learn more with @guyfagherazzi.bsky.social & Abir Elbeji.

🎧👉 www.easd.org/media-centre...

We work very hard to ensure a future where diabetes care is not just about numbers, but also about improving quality of life and psychological health. 🙌

👉 Check out the full study here, in Open Access: onlinelibrary.wiley.com/doi/10.1111/...

💙

#Diabetes #T1D #DigitalEpidemiology #MentalHealth

🌟 Congratulations to two amazing members from the Deep Digital Phenotyping Lab at the Luxembourg Institute of Health: Dulce Canha , brilliant PhD student working on T1D and distress in the e-cohorte SFDT1 study, and Gloria Aguayo, our senior scientist, for leading this clinically-relevant work!

🔑 But here’s the key takeaway: Even the best diabetes technology can’t take away the burden of diabetes entirely. While AIDs are a step forward, they don’t erase the daily challenges of living with or caring for someone with diabetes.

💡 Here’s What We Found: 
- For adults, AIDs brought a small but real drop in diabetes distress. 
- Caregivers saw moderate relief, with the greatest benefits for parents of younger kids. 
- Kids & teens showed no significant change, reminding us how much stress still rests on families.

Our latest study in Diabetic Medicine 📖 assessed how an automated insulin delivery system (AID) initiation impacts dîabetes distress for people living with it and their caregivers.

🚨 New Publication Alert! 🚨

Living with type 1 diabetes #T1D is a 24/7 challenge that takes a toll—not just on the body, but on emotional well-being too. However, some still think that the new diabetes technologies are the solution to everything. The situation is way more complex.

🍫Important fun fact before #Xmas: Type 2 diabetes risk reduction with increased dark chocolate consumption vs. Milk chocolate associated with weight gain

Paper in the BMJ on 3 US cohort studies 👉https://www.bmj.com/content/387/bmj-2023-078386

#epidemiology #nutrition #prevention #diabetes #T2D

Are you working in healthcare & interested to find out how Voice AI can transform healthcare? Join Guy Fagherazzi & key AI experts at the forefront of Voice and AI research at AMLD EPFL 2025. Get tickets before December 11 to benefit from early bird rates. 2025.appliedmldays.org/media-12-reg...

#VoiceAI #VocalBiomarkers #DigitalHealth #AI #ClinicalResearch #Healthcare #DigitalBiomarkers #Research

2️⃣. USA (Tampa, FL) - April 22-23, 2025 (Symposium) + April 24, 2025 (Hackathon) - Bridge2AI - Voice - Voice AI Symposium / Call for Science (Deadline December 15, 2024) and Registration info here 👉 www.eventsquid.com/event.cfm?id...

AMLD 2025 - Registration Online registration is now open! Early bird rates available until December 11, 2024 Key information before you register: You do not need to create an account to register for the event Rates vary by...

1️⃣. Europe (Switzerland) - February 11, 2025: @appliedmldays.bsky.social - Applied Machine Learning Days : "The Power of Voice AI to Transform Healthcare" / Registration 👉 2025.appliedmldays.org/media-12-reg... / @marcelsalathe.bsky.social

🗓️ 2025 is going to be the year of #VoiceAI 🗣️! If you're into #AI, vocal biomarkers, or #DigitalHealth, save these dates. Big events are happening in #Europe and the #US next year—you won’t want to miss them!

Next step in this collaboration: developing an #AI based detection system of eating disorders for clinical practice to better identify at risk individuals and offer proper care.

2) insulin omission is what actually matters the most when it comes to glycemic control (assessed with Hba1c and CGM), more than eating disorders per se

3) #diabetesdistress is frequently co-occuring with eating disorders in T1D

He updated the team with the main findings and he showed that:

1) eating disorders are more frequent in people with type 1 diabetes than the general population

Patrick is a professor in #nutrition in Toulouse France and a visiting scientist in our lab.

He develops a research project on type 1 diabetes #T1D and eating disorders using the SFDT1 cohort data, in collaboration with our very own Dr Gloria Aguayo.

Patrick Ritz presenting research results on eating disorders in type 1 diabetes

🎄It is with a #Xmas vibe that the Deep Digital Phenotyping Lab Luxembourg Institute of Health welcomed Pr Patrick Ritz to the lab today🎄.

#research #type1diabetes #t1d #epidemiology

Let us connect!

Home - Colive Voice Colive Voice, an international digital health study aims to improve diagnosis and monitoring of cancer, diabetes and COVID-19, by evaluating voice features.

We are managing the large #ColiveVoice study, a worldwide platform to collect voice data to develop #vocalbiomarkers

www.colivevoice.org

Deep Digital Phenotyping Research Unit » Luxembourg Institute of Health The Deep Digital Phenotyping Lab aims to leverage digital health technologies to identify digital biomarkers for enhanced disease monitoring.

Our lab is called Deep Digital Phenotyping and is in the Department of Precision Health at the Luxembourg Institute of Health.

www.lih.lu/en/research-...

Welcome to my account! I will mostly post about the following topics: #diabetes #type1diabetes #type2diabetes #epidemiology #clinicalresearch #AI #precisionhealth.

And cool research on using #voice and #AI to develop vocal biomarkers to develop vocal biomarkers for health monitoring.